Angeliki Sarella

ORCID: 0000-0002-1100-4627 · 2 papers in corpus · active 2024

Study types

  • article 1
  • erratum 1
erratum 2024
·doi:10.61873/fvlx2571

Due to an unfortunate oversight of the corresponding author, Anastasia Bothou was included as an author of the editorial without her consent and knowledge. The citation of the editorial has now been amended as follows: Iatrakis G., Zervoudi…

article 2024
·doi:10.61873/oefm7580

Tamoxifen is a nonsteroidal selective estrogen receptor modulator that is used mainly for adjuvant treatment of estrogen receptor-positive breast cancer. However, tamoxifen, due to its estrogen-mimicking effects, has been linked to various …